Regiocontrolled synthesis and HIV inhibitory activity of unsymmetrical binaphthoquinone and trimeric naphthoquinone derivatives of conocurvone

被引:50
作者
Stagliano, Kenneth W.
Emadi, Ashkan
Lu, Zhenhai
Malinakova, Helena C.
Twenter, Barry
Yu, Min
Holland, Louis E.
Rom, Amanda M.
Harwood, John S.
Amin, Ronak
Johnson, Allison A.
Pommier, Yves [1 ]
机构
[1] NCI, Mol Pharmacol Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA
[2] IIT, Dept Biol Chem & Phys Sci, Chicago, IL 60616 USA
[3] IIT, Res Inst, Chicago, IL 60616 USA
[4] Univ Illinois, Dept Chem, Chicago, IL 60607 USA
关键词
biquinones and trimeric quinones; HIV-1 integrase inhibitor; regiocontrolled synthesis; conocurvone;
D O I
10.1016/j.bmc.2006.04.034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Unsymmetrical biquinone and trimeric quinone derivatives were synthesized using halotriflate-biselectrophilic naphthoquinones through stepwise regioselective quinone substitution chemistry and evaluated for their ability to inhibit the cytopathogenic effects of HIV-1 using an MTT colorimetric assay. Compounds were also screened for their ability to inhibit the activity of HIV-1 integrase in vitro. Pyranylated trimeric quinones and biquinones exhibited both antiviral activity and integrase inhibitory activity. Conocurvone 1 and trimeric quinone 21 were the most potent HIV integrase inhibitors in the series. All of the biquinones showed HIV inhibitory activity. Simple methoxy substituted biquinones did not inhibit HIV-1 integrase. Published by Elsevier Ltd.
引用
收藏
页码:5651 / 5665
页数:15
相关论文
共 59 条
[41]   HIV integrase inhibitors with nucleobase scaffolds: Discovery of a highly potent anti-HIV agent [J].
Nair, V ;
Chi, G ;
Ptak, R ;
Neamati, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) :445-447
[42]  
Neamati N, 2000, Adv Pharmacol, V49, P147
[43]   HIV-1 integrase pharmacophore: Discovery of inhibitors through three-dimensional database searching [J].
Nicklaus, MC ;
Neamati, N ;
Hong, HX ;
Mazumder, A ;
Sunder, S ;
Chen, J ;
Milne, GWA ;
Pommier, Y .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) :920-929
[44]  
Ostlind D.A., 1991, U.S. Patent, Patent No. [5 017 603, 5017603]
[45]  
OSTLIND DA, 1991, CHEM ABSTR 41978, V115
[46]   New class of HIV integrase inhibitors that block viral replication in cell culture [J].
Pannecouque, C ;
Pluymers, W ;
Van Maele, N ;
Tetz, V ;
Cherepanov, P ;
De Clercq, E ;
Witvrouw, M ;
Debyser, Z .
CURRENT BIOLOGY, 2002, 12 (14) :1169-1177
[47]   RAPID AND AUTOMATED TETRAZOLIUM-BASED COLORIMETRIC ASSAY FOR THE DETECTION OF ANTI-HIV COMPOUNDS [J].
PAUWELS, R ;
BALZARINI, J ;
BABA, M ;
SNOECK, R ;
SCHOLS, D ;
HERDEWIJN, P ;
DESMYTER, J ;
DECLERCQ, E .
JOURNAL OF VIROLOGICAL METHODS, 1988, 20 (04) :309-321
[48]   Integrase inhibitors to treat HIV/AIDS [J].
Pommier, Y ;
Johnson, AA ;
Marchand, C .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (03) :236-248
[49]   INTEGRATION IS ESSENTIAL FOR EFFICIENT GENE-EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
SAKAI, H ;
KAWAMURA, M ;
SAKURAGI, JI ;
SAKURAGI, S ;
SHIBATA, R ;
ISHIMOTO, A ;
ONO, N ;
UEDA, S ;
ADACHI, A .
JOURNAL OF VIROLOGY, 1993, 67 (03) :1169-1174
[50]  
SHIBATA S, 1966, TETRAHEDRON LETT, P4855